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A commentary on
There’s been a flaw in our thinking
by Anderson CL. Front Immunol (2014) 5:540. doi: 10.3389/fimmu.2014.00540
We thank the editors for the opportunity to address the overstatements in the recent opinion article
(1). Over the past two decades, the role of FcRn in regulating the levels and transport of IgG in the
body has been established (2–5), validating the insightful prediction of Brambell in the 1960s that
IgG is salvaged from catabolism by receptors located within cellular compartments and/or on the
surface of cells (6, 7). Remarkably, this hypothesis was made in the absence of knowledge of the
molecular details of IgG–FcRn interactions. It is now well known that FcRn binds to IgG at acidic
pH (~6.0) with very low or negligible affinity at pH 7–7.4 (8–11), providing an elegant biological
solution to achieve exocytic release of recycled IgG. Further, the negligible binding of IgG to FcRn at
pH 7–7.4 supports the concept that fluid-phase, pinocytic uptake is the primary mediator of ligand
entry into cells exposed to this pH range. However, in the absence of information concerning the
pH dependence of FcRn–IgG interactions around 50 years ago, it was not possible to postulate the
mechanism of IgG uptake into cells bathed at acidic pH. Notably, in the light of the pH dependence
of complex formation, receptor-mediated internalization of IgG for cells at acidic pH is expected
to represent a major pathway, although this does not preclude the occurrence of concomitant
fluid-phase processes. Consequently, the relative contributions of fluid-phase vs. receptor-mediated
pathways for IgG internalization are highly dependent on the pH of the extracellular environment.
Further, FcRn biology has been enriched over the past decade by the recognition of its much broader
expression pattern and the elucidation of its role in multiple diverse processes, including antigen
presentation and mucosal immunity (12–15). Collectively, these developments have motivated
multiple in vitro cellular studies under conditions designed to emulate the physiological environment
of interest.
Numerous analyses of FcRn/IgG trafficking have been performed using cells bathed in medium
containing relatively high concentrations (~1–17μM) of wild type IgG at pH 7.0–7.4 to enable
fluid-phase, pinocytic uptake (16–22). Importantly, IgGs that bind with negligible affinity to FcRn
accumulate in cells under these conditions (18, 21). Reciprocally, the use of low concentrations
(~130 nM) of IgGs that bind to FcRn with the typical pH dependence results in almost background
levels of internalization (23). The endosomal sorting of fluorescently labeled wild type IgG in
FcRn-expressing endothelial cells has been analyzed at near neutral pH using IgG concentrations
(~3–7μM) that favor fluid-phase uptake (18). These studies demonstrated that IgG is quantitatively
routed within sorting (or early) endosomes in association with FcRn into tubulovesicular transport
carriers, supporting the concept that sorting endosomes are major sites of FcRn-mediated recycling
of IgG following pinocytosis. By contrast, an engineered IgG (H435A mutant) that does not bind
to FcRn accumulates in the vacuole of the sorting endosomes and is subsequently delivered to
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lysosomes. In a related study, exocytic processes involving FcRn
and wild type IgG have been characterized at the single molecule
level following exposure of cells to relatively high IgG concentra-
tions at pH 7.4 (19). Further, IgG recycling and saturation of FcRn
recycling pathways (21, 23, 24) were quantitated under similar
conditions. Analyses of the transport of wild type IgG within
endothelial, trophoblast and renal epithelial cells have also been
performed analogously (16, 17, 20). In light of these studies, the
statement advanced by the author of the recent opinion article
that “it proved virtually impossible to perform in vitro studies of
IgG uptake by cultured cells unless the medium was acidic” is
perplexing.
In any studies of receptor/ligand trafficking, it is essential to
distinguish the behavior of ligand from that of receptor. Con-
sidering the negligible affinity of most naturally occurring IgGs
for FcRn at near neutral pH, these ligands are unsuitable for use
in labeled form as FcRn tracers under these conditions. Conse-
quently, engineered IgG ligands with increased affinity for FcRn
at pH ~7 have been used at low concentrations (10–30 nM) that
result in negligible fluid-phase pinocytosis (23) to track receptor
during endocytosis and trafficking to sorting endosomes (25,
26). Parenthetically, these engineered antibodies compete very
effectively with wild type IgG for FcRn binding and therefore
have utility as IgG depleting agents in therapy and diagnosis
(27, 28). The potential applications of antibodies of this class
(“Abdegs”) have motivated analyses of their subcellular traffick-
ing behavior using conditions where receptor-mediated uptake
predominates (23, 29).
By contrast with analyses at near neutral pH, experiments have
been conducted using acidic pH to mimick the in vivo envi-
ronment corresponding to biological systems for which this is
appropriate, such as the apical surface of gut epithelium. These
cells are exposed to an acidic microenvironment due to the
activity of Na+/H+ exchangers (30). These conditions enable
receptor-mediated endocytosis of IgGs at low concentrations that
limit fluid-phase accumulation (23, 31, 32). This experimental
design results in FcRn-mediated transcytosis and/or recycling
[e.g., Ref. (3, 5, 33–35)], and multiple studies including electron
tomographic analyses validate the physiological relevance of this
approach [e.g., Ref. (31, 36)]. Anderson questions the validity of
bathing cells at acidic pH, substantiating his argument with “Gut
pH had been measured only once, with litmus paper, and the
observation was never repeated.” This statement is surprising, as
publications can readily be found in which different techniques
demonstrate that the pH of the proximal portion of the intestinal
lumen is mildly acidic [pH 6–7 (37, 38)]. For instance, this is well
illustrated clinically with the post-pyloric feeding tube placement
pH testing in neonates and children (39, 40).
Further, the argument of the author of the recent opinion
article that there is a minimal receptor-mediated internalization
by (epithelial) cells at acidic pH due to the low proportion of FcRn
present on the cell surface relative to intracellular levels neglects
consideration of receptor dynamics. Specifically, the low steady
state levels of FcRn on the plasma membrane do not exclude
the possibility of rapid receptor endocytosis following exocytic
events. Indeed, the observation that engineered antibodies with
high affinity for FcRn at near neutral pH efficiently accumulate
to relatively high levels within cells of multiple different lineages,
but only if the cells express FcRn, is consistent with such dynamic
cycling behavior (32).
In summary, the primary conclusion that the subcellular path-
ways taken by IgG following fluid-phase, pinocytic uptake into
cells have been ignored for two decades is unfortunately premised
on a highly selective review of the literature. To the contrary, a cur-
sory survey of the relevant publications clearly demonstrates that
Brambell’s model for regulating IgG homeostasis and transport by
receptor-mediated salvage has formed the conceptual foundation
to investigate these processes using modern experimental tools.
Beyond Brambell’s predictions, the discovery of new and unex-
pected roles for FcRn has also prompted experiments tailored to
specifically investigate the biological questions at hand.
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